HOXC10 promotes carboplatin resistance of ovarian cancer by regulating ABCC3.

Li, Yuanyuan; Lei, Han; Hai, Rihan; Shu, Guang; Yan, Wenguang; Yin, Gang.

Afiliação

Li Y; Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University Changsha, Hunan, China.
Lei H; Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University Changsha, Hunan, China.
Hai R; Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University Changsha, Hunan, China.
Shu G; Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University Changsha, Hunan, China.
Yan W; Department of Rehabilitation Medicine, Third Xiangya Hospital, Central South University Changsha, Hunan, China.
Yin G; Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University Changsha, Hunan, China.

Am J Cancer Res ; 12(10): 4602-4621, 2022.

Article em En | MEDLINE | ID: mdl-36381312